AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma

NCT07729618 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1800

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Hepatocellular Carcinoma

Interventions

OTHER: AI-Assisted Clinical Decision Support Strategy
OTHER: Usual-Care Multidisciplinary Treatment-Selection Strategy

Sponsor

Tongji Hospital